# Krebs-Therapiestudien

**Funder:** Deutsche Krebshilfe
**Application:** 2-stage: short application (Teil I) → full application (Teil II, by invitation only)
**Frequency:** Continuous
**Eligible countries:** DE
**Official call:** https://www.krebshilfe.de/forschen/foerderung/foerderprogramme/krebstherapiestudien/
**Last verified:** 26 July 2026

## Eligibility & scope

Funds non-commercial, investigator-initiated cancer therapy trials (Investigator Initiated Trials). Applicants submit a short-form Part I application; Part II is submitted only upon invitation from Deutsche Krebshilfe. Requires patient recruitment plan and sponsor declaration. Proposals must be submitted in German.

## Summary

Deutsche Krebshilfe's Krebs-Therapiestudien programme funds non-commercial, investigator-initiated cancer therapy trials (IITs) in Germany on a rolling basis. Researchers submit a short-form Part I application; successful proposals are invited to submit a full Part II application. All proposals must be submitted in German and include a patient recruitment plan and sponsor declaration.

## Who should apply

- Researchers designing non-commercial, investigator-initiated cancer therapy trials
- Applicants based at German institutions with capacity to recruit patients
- Clinical researchers with access to patient populations and trial infrastructure
- Teams prepared to submit applications in German and provide sponsor declarations

## Key dates

- Rolling deadline, applications accepted at any time
- Two-stage: Part I short application, then Part II full application by invitation only

## Tips for applicants

- The Part I short application is a competitive filter, clarity and feasibility of the patient recruitment plan are decisive.
- Sponsor declaration must be in place before submission; confirm institutional support early to avoid delays in Part II.

## Frequently asked questions

### What type of research does Deutsche Krebshilfe fund under Krebs-Therapiestudien?

Non-commercial, investigator-initiated cancer therapy trials (IITs) designed and led by researchers, not pharmaceutical industry-sponsored studies.

### How does the application process work for Krebs-Therapiestudien?

Applicants submit a short Part I application; Deutsche Krebshilfe invites successful proposals to submit a full Part II application.

### Can I submit a Krebs-Therapiestudien application any time?

Yes, the programme has a rolling deadline and accepts applications at any time.

### Do I need a sponsor declaration to apply?

Yes, a sponsor declaration is a mandatory requirement for Krebs-Therapiestudien applications.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/deutsche-krebshilfe-krebs-therapiestudien-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).